Melanocytes in psoriasis: convicted culprit or bullied bystander?
Melanocytes in psoriasis: convicted culprit or bullied bystander?
复制标题
牛皮癣中的黑色素细胞:被定罪的罪魁祸首还是被欺负的旁观者?
DOI:
10.1111/pcmr.12470
复制
发表时间:
2016
影响因子:
4.3
通讯作者:
Harris,JohnE
中科院分区:
文献类型:
--
作者:
Strassner,JamesP;Rashighi,Mehdi;Harris,JohnE
A recent study published in the Journal of Experimental Medicine reports that melanocytes may be targets of autoreactive T cells in psoriasis. Psoriasis is a common inflammatory disease of the skin that affects 1–3% of people worldwide. It presents with well-demarcated, scaly plaques that reduce the quality of life of affected patients (Lowes et al. 2014). Historically, psoriasis was thought to be a disorder of keratinocyte hyperproliferation, but most investigators now agree the driving force behind the disease is a dysregulated immune signaling cascade that results in the characteristically inflamed psoriatic lesions (Lowes et al. 2014). There is an ongoing debate whether the disease is truly autoimmune in origin, and if it is, it remains unclear what specific antigens, let alone which cell types, are the targets of this autoimmune response.The pathogenesis of psoriasis is mediated by several immune populations in the skin, and many of the inflammatory pathways involved are now well described. These pathways lead to continued immune cell recruitment, inflammation, and the unrestrained proliferation of keratinocytes, which gives rise to the thickened, scaly plaques (Lowes et al. 2014). In the chronic inflammatory phase of the disease, T cells play a prominent role, which may produce Th1, Th17 or Th22-specific cytokines. Of these, the IL-23/IL-17/TNF-α axis appears to be central to disease pathogenesis, as targeting this axis for treatment results in vast improvement of the disease (Lowes et al. 2014). Classically, IL-17 producing cells were thought to be αβ T cells, but more recent studies of psoriasis in both humans and mice have revealed an emerging role of γδ T cells as additional contributors (Lowes et al. 2014). This has important implications for antigen targeting in the disease, as αβ T cells recognize specific antigens in the context of HLA presentation, while γδ T cells do not.